retatrutide and tirzepatide vs (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide vs Tirzepatide vs Semaglutide

While there is limited evidence regarding tirzepatide use specifically in patients with significant thyroid disease (as these patients were typically excluded from pivotal trials), there is no established direct pharmacological interaction between tirzepatide and Graves disease pathophysiology

Romosozumab carries a black box warning for increased cardiovascular risk, including heart attack, stroke, and cardiovascular death

Cardiovascular Benefits: Research has shown that GLP-1 receptor agonists can reduce cardiovascular risk factors, including lowering blood pressure, reducing inflammation, and improving lipid profiles

Recent data have indicated that such an effect may depend on the influence on metabolic processes because in chronic unpredictable mild stress (CUMS) in mice, the decreased GLP-1 level in the hippocampus was increased with metformin treatment [46]